WO2002078602A3 - Transdermal delivery of pergolide - Google Patents

Transdermal delivery of pergolide Download PDF

Info

Publication number
WO2002078602A3
WO2002078602A3 PCT/US2002/010057 US0210057W WO02078602A3 WO 2002078602 A3 WO2002078602 A3 WO 2002078602A3 US 0210057 W US0210057 W US 0210057W WO 02078602 A3 WO02078602 A3 WO 02078602A3
Authority
WO
WIPO (PCT)
Prior art keywords
transdermal delivery
affixed
face
pergolide
matrix
Prior art date
Application number
PCT/US2002/010057
Other languages
French (fr)
Other versions
WO2002078602A2 (en
Inventor
Debra A Martin
Jesus Miranda
Adolfo Leonel Vanegas
Original Assignee
Elan Transdermal Technologies
Debra A Martin
Jesus Miranda
Adolfo Leonel Vanegas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Transdermal Technologies, Debra A Martin, Jesus Miranda, Adolfo Leonel Vanegas filed Critical Elan Transdermal Technologies
Priority to CA002443128A priority Critical patent/CA2443128A1/en
Priority to JP2002576871A priority patent/JP2005506297A/en
Priority to EP02757900A priority patent/EP1385459A2/en
Priority to US10/473,511 priority patent/US20040120995A1/en
Publication of WO2002078602A2 publication Critical patent/WO2002078602A2/en
Publication of WO2002078602A3 publication Critical patent/WO2002078602A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A transdermal delivery device comprising a multi-phase matrix which includes a solid liquid-retaining member and associated therewith pergolide in liquid form, for example, a transdermal delivery device comprising a barrier layer affixed to one face of the matrix and having an exposed face, the exposed face having affixed thereto a mounting layer, and the other face of the matrix having affixed thereto a removable layer, an example of the liquid-retaining member being an absorbent material, for example, a natural or synthetic fiber gauze, a non-woven medical basorbent, a natural sponge, and a synthetic sponge.
PCT/US2002/010057 2001-03-30 2002-04-01 Transdermal delivery of pergolide WO2002078602A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002443128A CA2443128A1 (en) 2001-03-30 2002-04-01 Transdermal delivery of pergolide
JP2002576871A JP2005506297A (en) 2001-03-30 2002-04-01 Pergolide transdermal delivery
EP02757900A EP1385459A2 (en) 2001-03-30 2002-04-01 Transdermal delivery of pergolide
US10/473,511 US20040120995A1 (en) 2002-04-01 2002-04-01 Transdermal delivery of pergolide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28053301P 2001-03-30 2001-03-30
US60/280,533 2001-03-30

Publications (2)

Publication Number Publication Date
WO2002078602A2 WO2002078602A2 (en) 2002-10-10
WO2002078602A3 true WO2002078602A3 (en) 2003-02-20

Family

ID=23073490

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/010057 WO2002078602A2 (en) 2001-03-30 2002-04-01 Transdermal delivery of pergolide

Country Status (4)

Country Link
EP (1) EP1385459A2 (en)
JP (1) JP2005506297A (en)
CA (1) CA2443128A1 (en)
WO (1) WO2002078602A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9289382B2 (en) 2012-06-18 2016-03-22 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10341317B4 (en) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermal therapeutic system (TTS) for administration of ergoline compounds except pergolide
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
NZ725354A (en) * 2014-06-18 2018-05-25 Elanco Us Inc Transdermal formulations of pergolide and uses thereof
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
WO1996040139A1 (en) * 1995-06-07 1996-12-19 Alza Corporation Novel formulations for transdermal delivery of pergolide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
WO1996040139A1 (en) * 1995-06-07 1996-12-19 Alza Corporation Novel formulations for transdermal delivery of pergolide

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9289382B2 (en) 2012-06-18 2016-03-22 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion

Also Published As

Publication number Publication date
EP1385459A2 (en) 2004-02-04
CA2443128A1 (en) 2002-10-10
WO2002078602A2 (en) 2002-10-10
JP2005506297A (en) 2005-03-03

Similar Documents

Publication Publication Date Title
WO2002078602A3 (en) Transdermal delivery of pergolide
WO2002078604A3 (en) Transdermal delivery of bioactive material
ES2118535T3 (en) PATCH CONTAINING AN ACTIVE PRINCIPLE.
AU2961802A (en) Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system
GB2382305B (en) Absorbent wound dressings containing a hydrogel layer
BR9916886B1 (en) absorbent elastic nonwoven material, personal care absorbent article and medical absorbent article.
BR9913351A (en) Disposable absorbent articles with improved adhesive for skin attachment
AU6403199A (en) Elastic laminate including nonwoven layer formed from highly oriented component fibers and disposable garment employing the same
SI1009393T1 (en) Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
BR9808272A (en) Cosmetic product for application of skin actives.
WO2007138287A3 (en) Friction tool for use in a cosmetic method
AU1800099A (en) Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
AU763798B2 (en) Plaster containing an active agent
GB0111755D0 (en) A wound dressing
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
FI972004A0 (en) An implantable device for administering active substances to plants
DE602004009060D1 (en) CUSHION FOR SKIN CLEANSING AND SKIN HUMIDIFICATION
JP2004051516A (en) Sheet-like pack
DK0865274T3 (en) Surface stabilized pharmaceutical composition for application to the skin
GR3035614T3 (en) Use of aromas and flavours to induce or change eating patterns
YU71293A (en) TRANSDERMAL THERAPY SYSTEM FOR THE PROMOTION OF PHYSOSTIGMIN ON THE SKIN AND THE PROCEDURE FOR ITS MAKING

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10473511

Country of ref document: US

Ref document number: 2002576871

Country of ref document: JP

Ref document number: 2443128

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002757900

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002757900

Country of ref document: EP